Polymorphic and amorphous salt forms of squalamine dilactate

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8716270
SERIAL NO

13166911

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to select squalamine salts, methods of their synthesis, their therapeutic use and their advantages relating to manufacturing, product stability and toxicity. More specifically, this application is directed to various forms of the dilactate salt of squalamine and their utility in inhibiting neovascularization and endothelial cell proliferation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ENTERIN INC2005 MARKET STREET SUITE 3125 PHILADELPHIA PA 19103

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Armbruster, Kyle Douglassville, US 2 20
Chellquist, Eric Douglassville, US 3 22
Doubleday, Mary Snohomish, US 5 60
Gilbert, Charles W Pottstown, US 1 0
Levitt, Roy C Miami, US 20 118
McLane, Michael Lansdale, US 26 107
Zhang, Xuehai Ellicott City, US 15 87

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 6, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00